The global orthopedic navigation systems market size was valued at USD 122.95 million in 2016 and is expected to grow at a CAGR of 10.6% over the forecast period. Rising base of geriatric population, increasing cases of joint reconstruction, increasing awareness levels among patients & healthcare professionals, and high level of healthcare expenditure are high growth rendering drivers.
U.S. orthopedic navigation systems market, by application, 2014-2025 (USD Million)
Associated advantages of computer-assisted surgeries, such as low blood loss, shorter hospital stay, and easier rehabilitation, are other factors expected to drive the industry revenue. Computer-Assisted Surgery (CAS) is instrumental in delivering accurate implant alignment, provides improved functionality, causes less pain & fewer complications, improves quality-adjusted life year, and causes less tissue damage.
There is significant blood loss during conventional joint replacement procedures. Studies have shown that only 9% blood transfusion is required during CAS as compared to 23% in conventional surgery. CAS has also been reported to reduce allogenic blood transfusion by 50%. CAS has been demonstrated to be more accurate in implant alignment and provides faster rehabilitation as compared to conventional procedures.
Due to the abovementioned factors, demand for minimally invasive surgery is increasing rapidly. Minimally invasive replacement surgery consists of lesser muscles and tendons distribution, making the reconstruction procedure more natural. Wound closure in these cases is easier and recovery time is also faster as compared to traditional procedures. Growing concern for natural and more aesthetic appearance across all age groups is a major growth driver. Lower blood loss during minimally invasive surgeries is also an added advantage. The aforementioned factors can be attributed to the rising demand over the forecast period.
Furthermore, technological advancement in the surgical navigation procedures, increasing incidence of osteoarthritis, and rise in funding pertaining to R&D are other factors expected to boost the demand.
Knee surgery segment dominated the overall market in terms of revenue in 2016. Increasing number of total knee replacement procedures and rising awareness pertaining to associated benefits are the factors contributing to its dominance over the forecast period. On the other hand, hip, and spine surgery segment is expected to witness a moderate growth over the forecast period due to lesser use of CAS and high cost of the instruments.
In addition, volume wise, knee surgery dominated the market in 2016 owing to greater penetration coupled with wider applications in multiple surgical conditions, such as total knee arthroplasty, unicompartmental (partial) knee replacement, kneecap replacement (patellofemoral arthroplasty), and revision knee replacement.
North America dominated in 2016 owing to the availability of improved infrastructure, high awareness levels, and favorable government initiatives pertaining to the promotion of orthopedic navigation system.
Global orthopedic navigation systems market share, by region, 2016
The Asia Pacific market is presumed to witness the fastest growth owing to the presence of high unmet clinical needs, increase in government initiatives to improve patient awareness related to minimally invasive procedures for replacement surgeries, and rising investments by manufacturers for production of cost-efficient orthopedic navigation systems.
Some key players of this industry are Stryker Corporation; Medtronic Inc.; Zimmer-Biomet, Inc.; Brainlab AG; Smith & Nephew; and Orthokey Italia SRL.These players accounted for majority of the market share in 2016. Stryker Corporation, owing to its extensive product portfolio, held the largest share. Its key products include Orthomap precision knee navigation software, Orthomap express knee navigation software, and Orthomap versatile hip navigation software. However, other players are also gaining market share due to mergers & acquisitions and new product development activities.
Key factors that can be attributed to the dominance of few players are presence of an extensive product portfolio and wide global distribution network. Brainlab AG dominated the orthopedic navigation system market as of 2016 owing to its extensive product portfolio, especially related to software assistance in the surgical navigation system, and strategic collaboration with other major players such as De Puy Synthase and Zimmer-Biomet.
In addition, the industry is facing intense competition as well established manufacturers influencing the pricing and technological trends. The competing technologies are presumed to drive down the cost of the products which thereby resulting into the reduction of profit margin of new entrants.
Report Attribute |
Details |
Market size value in 2020 |
USD 182.43 million |
Revenue forecast in 2025 |
USD 303.7 million |
Growth Rate |
CAGR of 10.6% from 2017 to 2025 |
Base year for estimation |
2016 |
Historical data |
2014 - 2016 |
Forecast period |
2017 - 2025 |
Quantitative units |
Revenue in USD million, volume in 000’units and CAGR from 2017 to 2025 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Application, region |
Regional scope |
North America; Europe; APAC; Latin America; MEA |
Country scope |
U.S.; Canada; UK; Germany; France; Japan; China; Brazil; Mexico; South Africa |
Key companies profiled |
Stryker Corporation; B Braun Melsungen AG; Brainlab AG; Zimmer Biomet, Inc.; MicroPort Medical; Amplitude SAS; DePuy Synthes, Inc; Medtronic; Orthokey Italia SRL; Smith & Nephew |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth and provides an analysis of the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global orthopedic navigation systems market on the basis of application, and region:
Application Outlook (Revenue, USD Million, Volume, 000’Units, 2014 - 2025)
Spine
Hip
Knee
Regional Outlook (Revenue, USD Million, Volume, 000’Units, 2014 - 2025)
North America
U.S
Canada
Europe
Germany
UK
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
The Middle East and Africa
South Africa
b. The global orthopedic navigation systems market size was estimated at USD 165.15 million in 2019 and is expected to reach USD 182.43 million in 2020.
b. The global orthopedic navigation systems market is expected to grow at a compound annual growth rate of 10.6% from 2018 to 2025 to reach USD 303.79 million by 2025.
b. North America dominated the orthopedic navigation systems market with a share of 43.37% in 2019. This is attributable the availability of improved infrastructure, high awareness levels, and favorable government initiatives pertaining to the promotion of orthopedic navigation system.
b. Some key players operating in the orthopedic navigation systems market include Stryker Corporation, B Braun Melsungen AG, Brainlab AG, Zimmer Biomet, Inc., MicroPort Medical, Amplitude SAS, DePuy Synthes, Inc, Medtronic, Orthokey Italia SRL, and Smith & Nephew.
b. Key factors that are driving the market growth include rising base of geriatric population, increasing cases of joint reconstruction, increasing awareness levels among patients & healthcare professionals, and high level of healthcare expenditure.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.